Status:
TERMINATED
Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Pancreatic Neoplasms
Eligibility:
All Genders
16+ years
Brief Summary
This study will examine pancreatic tumor tissue and immune cells from patients with a pancreatic tumor to look for markers on these cells that may be useful in developing new treatments for the diseas...
Detailed Description
Background: * Effective standard treatment options are currently not available for exocrine pancreas carcinomas. Adenocarcinoma of the pancreas, the most frequent exocrine tumor, is the fourth leadin...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA
- Any patient greater than or equal to 16 years of age with radiographic or endoscopic evidence of a pancreatic mass, ampullary mass or malignant stricture without evidence of distant metastases.
- Recovered from any serious toxicity experienced during previous treatment (chemo-, radiation, hormone, immuno-, etc., therapy) for pancreas cancer to a grade 2 or less.
- ECOG Performance Status greater 0-2.
- Must have laboratory and physical examination parameters within acceptable limits by standard of practice guidelines prior to surgery.
Exclusion
Key Trial Info
Start Date :
December 21 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 20 2012
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00100321
Start Date
December 21 2004
End Date
November 20 2012
Last Update
December 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892